Medidata Solutions Stock Price, News & Analysis (NASDAQ:MDSO)

Medidata Solutions trades on the NASDAQ under the ticker symbol "MDSO."

Medidata Solutions Inc (NASDAQ:MDSO) announced its quarterly earnings data on Monday, July, 22nd. The company reported $0.48 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.17 by $0.31. The business had revenue of $180.50 million for the quarter, compared to analyst estimates of $179.95 million. Medidata Solutions had a net margin of 6.43% and a return on equity of 8.64%. The company's revenue was up 15.8% on a year-over-year basis. During the same period last year, the business earned $0.43 EPS. View Medidata Solutions' Earnings History.

Medidata Solutions is scheduled to release their next quarterly earnings announcement on Thursday, October 17th 2019. View Earnings Estimates for Medidata Solutions.

9 analysts have issued 12 month target prices for Medidata Solutions' stock. Their forecasts range from $70.00 to $96.00. On average, they expect Medidata Solutions' share price to reach $84.4288 in the next twelve months. This suggests that the stock has a possible downside of 8.0%. View Analyst Price Targets for Medidata Solutions.

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medidata Solutions in the last year. There are currently 8 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Medidata Solutions.

Media headlines about MDSO stock have trended somewhat negative this week, according to InfoTrie Sentiment Analysis. The research group scores the sentiment of press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Medidata Solutions earned a coverage optimism score of -1.3 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for Medidata Solutions.

Some companies that are related to Medidata Solutions include Veeva Systems (VEEV), Synopsys (SNPS), Splunk (SPLK), Cadence Design Systems (CDNS), ANSYS (ANSS), Check Point Software Technologies (CHKP), Atlassian (TEAM), Twilio (TWLO), Crowdstrike (CRWD), Symantec (SYMC), Tableau Software (DATA), TAKE-TWO INTERACTIVE SOFTWARE (TTWO), Paycom Software (PAYC), SS&C Technologies (SSNC) and Citrix Systems (CTXS).

Based on aggregate information from My MarketBeat watchlists, some companies that other Medidata Solutions investors own include NVIDIA (NVDA), Applied Materials (AMAT), salesforce.com (CRM), Gilead Sciences (GILD), Allergan (AGN), GrubHub (GRUB), IBM (IBM), Celgene (CELG), Alphabet (GOOG) and Intel (INTC).

Medidata Solutions' stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (8.98%), BlackRock Inc. (8.99%), Vanguard Group Inc. (8.75%), Brown Capital Management LLC (6.30%), Janus Henderson Group PLC (2.48%) and Janus Henderson Group PLC (2.48%). Company insiders that own Medidata Solutions stock include Carlos Dominguez, Daniel Patrick Shannon, Lee Shapiro, Michael I Otner, Michael L Capone, Michael Pray, Robert Taylor, Rouven Bergmann and Tarek Sherif. View Institutional Ownership Trends for Medidata Solutions.

MDSO stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., BlackRock Inc., ARK Investment Management LLC, Eagle Asset Management Inc., Bank of New York Mellon Corp, Global Thematic Partners LLC, Pictet Asset Management Ltd. and Peregrine Capital Management LLC. Company insiders that have sold Medidata Solutions company stock in the last year include Daniel Patrick Shannon, Michael I Otner, Michael Pray, Robert Taylor and Rouven Bergmann. View Insider Buying and Selling for Medidata Solutions.

MDSO stock was purchased by a variety of institutional investors in the last quarter, including Alpine Associates Management Inc., Magnetar Financial LLC, Echo Street Capital Management LLC, ARP Americas LP, Morgan Stanley, Syquant Capital Sas, Pentwater Capital Management LP and Water Island Capital LLC. View Insider Buying and Selling for Medidata Solutions.

Shares of MDSO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of MDSO stock can currently be purchased for approximately $91.74.

Medidata Solutions has a market capitalization of $5.73 billion and generates $635.70 million in revenue each year. The company earns $51.92 million in net income (profit) each year or $0.96 on an earnings per share basis. Medidata Solutions employs 1,998 workers across the globe.View Additional Information About Medidata Solutions.

The official website for Medidata Solutions is http://www.mdsol.com/.

Medidata Solutions' mailing address is 350 HUDSON ST. 9TH FLOOR, NEW YORK NY, 10014. The company can be reached via phone at 212-918-1800 or via email at [email protected]